Alyeska Investment Group
WST icon

Alyeska Investment Group’s West Pharmaceutical WST Stock Holding History

Alyeska Investment Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-154,440
Closed -$57.9M – 672
2023
Q3 		$57.9M Buy
+154,440
New +$59.7M 0.39% 85
2023
Q2 		– Sell
-227,349
Closed -$78.8M – 638
2023
Q1 		$78.8M Buy
+227,349
New +$66.4M 0.69% 41
2022
Q4 		– Sell
-201,854
Closed -$49.7M – 525
2022
Q3 		$49.7M Buy
201,854
+45,302
+29% +$13.8M 0.58% 54
2022
Q2 		$47.3M Buy
+156,552
New +$50.9M 0.54% 48
2020
Q2 		– Sell
-4,988
Closed -$759K – 582
2020
Q1 		$759K Buy
+4,988
New +$768K 0.02% 317
2018
Q2 		– Sell
-219,058
Closed -$19.3M – 535
2018
Q1 		$19.3M Buy
+219,058
New +$20.5M 0.16% 161

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alyeska Investment Group's WST Position: Q4 2023 in Review

Alyeska Investment Group sold out of West Pharmaceutical (WST) in Q4 2023, closing a stake of 154,440 shares — an estimated $57.9M sold.

Alyeska Investment Group first reported a position in WST in Q1 2018 and held it in 6 quarters. The position peaked at $78.8M in Q1 2023. 782 funds tracked by Wall St. Rank hold WST as of Q4 2023.

  • Alyeska Investment Group reported no remaining West Pharmaceutical position as of Q4 2023 after selling out during the quarter.
  • Alyeska Investment Group sold 154,440 West Pharmaceutical shares in Q4 2023, an estimated $57.9M.
  • Alyeska Investment Group first reported a position in West Pharmaceutical in Q1 2018 and held it in 6 quarters.
  • Alyeska Investment Group's West Pharmaceutical position peaked at $78.8M in Q1 2023.
  • 782 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2023.

Based on Alyeska Investment Group's 13F filing for Q4 2023, filed 14 Feb 2024.